May 22, 2024
Mynvax, a clinical stage vaccine biotechnology company, was founded with the singular vision of developing novel, improved, recombinant, thermostable vaccines to protect against respiratory viral infections.
Privacy Notice | © 2024, FSID, IISc | Designed by Applied Wonder